Brookdale Senior Living Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Brookdale Senior Living Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	4,977	4,747	4,531	4,057	3,540	2,758	2,825	3,016	3,125	3,194
Gross profit	1,440	1,254	1,068	877	797	501	594	747	799	838
General and administrative	313	278	259	219	207	185	169	179	186	195
Operating income	-31.1	-270	-594	-44.5	-97.7	-217	-42.7	18.4	46.5	13.5
Interest expense	386	326	280	248	209	195	205	238	253
Interest income	2.93	4.62	9.85	9.86	4.8	1.35	6.94	23.1	19.2	12.4
Other non-operating income	14.8	11.4	14.1	14.8	5.65	5.9	12.1	21.7	9.38	3.8
Pre-tax income	-399	-588	-578	-271	87.3	-108	-240	-180	-197	-265
Income tax	5.38	-16.5	-49.5	-2.27	5.35	-8.16	-1.56	8.78	4.65	-1.95
Net income to minority interests	-0.24	-0.19	-0.09	-0.56	-0.07	-0.07	0.09	-0.06	-0.06	-0.05
Net income	-404	-571	-528	-268	82	-99.3	-238	-189	-202	-263
EBITDA	499	225	-139	339	268	128	311	369	414	384
EPS, basic	-2.18	-3.07	-2.82	-1.44	0.45	-0.54	-1.25	-0.84	-0.89	-1.12
EPS, diluted	-2.18	-3.07	-2.82	-1.44	0.44	-0.54	-1.25	-0.84	-0.89	-1.12
Shares, basic (weighted)	186	186	187	186	183	185	190	225	228	235
Shares, diluted (weighted)	186	186	187	186	184	185	190	225	228	235

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	216	223	398	240	380	347	399	278	309	279
Short-term investments	0	292	14.9	68.6	173	182	48.7	29.8	19.9	0
Receivables	142	129	134	134	109	51.1	55.8	48.4	51.9	67.7
Other current assets	131	115	106	84.2	66.9	87.9	106	80.9	92.4	96.7
Total current assets	620	902	774	596	774	699	637	478	513	554
Property, plant and equipment	7,379	5,852	5,275	5,110	5,068	4,904	4,536	4,331	4,594	4,273
Lease right-of-use assets			0	1,160	788	630	597	671	1,134	1,032
Goodwill	705	506	154	154	154	27.3	27.3	27.3	27.3	27.3
Intangible assets	83	68	51.5	35.2	34.1
Other non-current assets	235	195	160	119	56.3	17.3	34.9	35.9	36	35.5
Total assets	9,218	7,675	6,467	7,194	6,902	6,410	5,937	5,573	6,336	5,952
Accounts payable	77.4	91.8	95	105	71.2	76.1	71	66.5	65.5	75.1
Accrued liabilities	328	330	298	267	288	255	237	243	264	273
Short-term debt	146	495	294	339	68.9	63.1	66	41.5	40.8	77.5
Total current liabilities	731	1,096	773	1,047	691	632	641	600	580	568
Long-term debt	3,414	3,375	3,346	3,216	3,847	3,778	3,784	3,656	4,022	4,215
Lease liabilities			0	1,277	819	682	617	684	1,174	1,124
Other non-current liabilities	231	215	197	169	188	86.8	85.8	71.7	69.2	58.5
Total liabilities	7,140	6,145	5,449	6,496	6,099	5,711	5,353	5,168	6,122	5,996
Total debt	6,045	5,142	3,640	3,555	3,916	3,841	3,850	3,697	4,063	4,292
Paid-in capital	4,102	4,127	4,151	4,172	4,212	4,209	4,332	4,342	4,353	4,358
Retained earnings	-1,970	-2,541	-3,069	-3,393	-3,311	-3,410	-3,649	-3,838	-4,040	-4,303
Treasury stock	-56.4	-56.4	-64.9	-84.7	-103	-103	-103	-103	-103	-103
Shareholders' equity	2,078	1,531	1,019	696	800	697	583	404	212	-44.8
Minority interests	-0.25	-0.44	-0.49	2.37	2.3	2.22	1.55	1.49	1.43	1.38
Total equity	2,078	1,530	1,018	699	803	700	584	405	214	-43.4
Total liabilities and equity	9,218	7,675	6,467	7,194	6,902	6,410	5,937	5,573	6,336	5,952
Shares outstanding	190	191	192	192	188	187	187	188	200	238

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-405	-572	-528	-268	81.9	-99.4	-238	-189	-202	-263
Depreciation and amortization	530	495	456	384	365	345	354	350	368	370
Stock-based compensation	32.3	27.8	26.1	23	20.7	16.3	14.5	12	14.2	11.9
Deferred income tax	3.25	-15.3	-52.4	-2.65	-5.84	-9.84	-1.32	7.59	3.62	-3.29
Change in receivables	1.58	12.7	-4.96	0.29	24.3	0.5	-4.62	7.38	-3.5	-15.8
Change in payables	-83.2	-4.53	-37.3	-13	27.3	-54	-27.2	2.45	15.7	4.46
Cash from operations	374	378	204	216	206	-94.6	3.28	163	166	218
Capital expenditures	-334	-214	-225	-304	-186	-177	-197	-233	-201	-202
Acquisitions	-12.2	-5.2
Purchases of investments	0	-341	-14.8	-186	-378	-362	-264	-174	-49.1	0
Sales and maturities of investments	0	50	293	134	275	353	399	197	60	20
Cash from investing	172	-602	289	-226	-425	181	-67.4	-113	-278	-456
Debt issued	387	1,307	607	322	963	353	254	206	766	918
Stock issued	0
Share buybacks	-9.64	0	-4.26	-24	-18.1	0	0
Cash from financing	-422	229	-325	-139	383	-114	100	-174	142	201
Net change in cash	128	5.22	168	-149	163	-26.8	36.2	-125	30.2	-36.8
Free cash flow	40	164	-21.5	-87.7	19.8	-271	-194	-70.3	-35.1	16.5
Interest paid	350	295	261	244	205	189	200	232	243	238
Income taxes paid	2.05	1.04	2.06	1.53	8.88	5.92	-0.33	-1.43	1.05	1.44

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $11.11 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	26.9%	Gross profit / revenue.
Operating margin	3.5%	Operating income / revenue.
EBITDA margin	14.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-4.4%	Pre-tax income / revenue.
Net margin	-4.5%	Net income / revenue.
FCF margin	0.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.3%	Cash from operations / revenue.
Return on assets (ROA)	-2.3%	Net income / average total assets.
Return on invested capital (ROIC)	2.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	6.6%	Capital expenditures / revenue.
D&A / revenue	10.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	2.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-2.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	4.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	12.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-71.0%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-7.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	7.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	7.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	31.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	305.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	1.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-3.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-121.1%	Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	-6.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	3.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	7.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	5.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.14x	Current assets / current liabilities.
Quick ratio	0.85x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.75x	(Cash + short-term investments) / current liabilities.
Debt / assets	72.4%	Total debt / total assets.
Liabilities / assets	100.5%	Total liabilities / total assets.
Net debt	$3.88B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	9.04x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$74.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	0.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$56.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.52x	Revenue / average total assets.
Fixed asset turnover	0.73x	Revenue / average property, plant and equipment.
Receivables turnover	54.1x	Revenue / average receivables.
Days sales outstanding	7 days	365 x average receivables / revenue.
Capex / operating cash flow	89.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.57	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$12.51	Revenue / diluted weighted shares.
FCF per share	$0.10	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.92	Cash from operations / diluted weighted shares.
Book value per share	-$0.12	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.24	Tangible book value / shares outstanding.
Cash per share	$1.63	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$2.65B	Share price x shares outstanding.
Enterprise value	$6.54B	Market cap + total debt - cash - short-term investments.
P/S	0.87x	Market cap / revenue.
P/FCF	112x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	11.9x	Market cap / cash from operations, when positive.
EV/Sales	2.14x	Enterprise value / revenue.
EV/EBIT	61.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	15.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	275x	Enterprise value / free cash flow, when both are positive.
FCF yield	0.9%	Free cash flow / market cap.
Earnings yield	-5.2%	Net income / market cap (the inverse of P/E).

What was Brookdale Senior Living Inc.'s revenue in fiscal 2025?

Brookdale Senior Living Inc. reported revenue of $3.19B for fiscal 2025, 2.2% higher than the year before.

Was Brookdale Senior Living Inc. profitable in fiscal 2025?

No. It reported a net loss of $262.7M.

How much free cash flow did Brookdale Senior Living Inc. generate in fiscal 2025?

Cash from operations of $218.0M minus capital expenditures of $201.5M left free cash flow of $16.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Brookdale Senior Living Inc.